XTalks

AUGUST 2, 2023

Most of the company’s revenue comes from the manufacture and sale of biopharmaceutical products. billion the drug generated in 2021. every eight weeks for the 90 mg dose, according to the manufacturer. First FDA-approved in March 2017, the list price of Ocrevus was about $75,102 annually, as reported by the manufacturer.

Sales 98

Sales Manufacturing FDA Approval Life Science 98

pharmaphorum

MARCH 3, 2022

Non-profit drugmaker Civica Rx has said it will launch biosimilars of three big-selling insulin products in the US by 2024 to help diabetic patients struggling with the cost of the drugs.

Insulin 52

Insulin Production Generic Drugs Medicine 52

Pharmacy Checkers

NOVEMBER 19, 2020

Not only do drug manufacturers have patents: they have special international trade protections where companies cannot import these same drugs from foreign wholesalers who charge much lower prices in Canada, not to mention the even lower prices in the UK and European Union countries – unless the drug manufacturers do the importing or authorize it.

Pharmacy 52

Pharmacy Insulin Branding Drugs 52

Pharma in Brief

AUGUST 9, 2021

Terms and conditions would be imposed after discussions with the manufacturer and would obligate them to take steps to manage risks and resolve uncertainties. An RMP summarizes the risks of a drug and the pharmacovigilance activities and other measures that a manufacturer puts in place to monitor and manage any identified risks.

Regulation 98

Regulation Drugs Manufacturing Production 98

XTalks

JANUARY 23, 2025

In its second interim staff report released January 14, 2025, the Federal Trade Commission (FTC) revealed that the top three pharma benefit managers (PBM) in the US inflated prices of specialty generic drugs over the past several years, resulting in them raking in billions of dollars in profits. What Is a PBM? billion in 2021.

Drugs 59

Drugs Generic Drugs Pharmacy Insulin 59

Pharmaceutical Technology

DECEMBER 4, 2022

For example, the first-to-market status was beneficial when it came to insulin biosimilars. But he says, “Given the number of biosimilar manufacturers and who those players are, there is going to be some real wrangling to make sure that these choices do come in. It is just a matter of time.”. Free Report.

Marketing 262

Marketing Pharmacy Production Branding 262

Pharmacy Checkers

MARCH 11, 2020

Permit personal drug import waivers to individual patients who must apply for the waivers, including with consent from their licensed practitioners. These are general examples of how the agency can implement (J)(2) to expressly permit more forms of safe personal drug importation, ones that don’t include ordering medicines online. (A)is

Pharmacy 41

Pharmacy Drugs FDA Approval Licensing 41